Cancer (UICC) Tumor Biology Committee to evaluate the results of dendritic cell-based immunotherapy for cancer patients. Suggested reading about this therapy is listed in the References. [1][2][3][4][5][6][7][8][9][10] The following are the recorded results of the workshop discussions. Individual pr
Report of UICC colorectal cancer screening workshop
โ Scribed by Graeme Young; Bernard Levin
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 133 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
International leaders in colorectal cancer screening have met and discussed topics in a semi-formal format that facilitated critical discussion. Four main areas were covered by the individual speakers. These are schematically summarized below.
๐ SIMILAR VOLUMES
The total costs (direct and indirect) associated with the operation of an Australian community based screening programme for colorectal cancer (CRC) were estimated. One-year costs of the programme were estimated to be AUS$1 347 948 to screen 24 000 participants. This corresponded to AUS$8868 per pol
The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female
## BACKGROUND. Although the efficacy of mass screening for colorectal carcinoma (CRC) with a fecal occult blood test has been demonstrated in several randomized trials, a mass screening approach used in countries with intermediate or low incidence of CRC might be costly. Screening high risk people